Surmodics | SRDX - Operating Expenses


Surmodics reported $29.51M in Operating Expenses for its fiscal quarter ending in June of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Align Technology USD 862.03M 39.18M Mar/2026
Anika Therapeutics USD 133.9M 103.93M Mar/2026
Arrowhead Research USD 215M 8.23M Mar/2026
Artivion USD 111.2M 9.45M Dec/2025
Baxter International USD 6.04B 2.85B Mar/2026
Boston Scientific USD 4.15B 107M Mar/2026
EDAP TMS EUR 18.8M 3.01M Sep/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
Heron Therapeutics USD 40.55M 1.46M Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Merit Medical Systems USD 337.72M 2.02M Mar/2026
Mesa Laboratories USD 33.98M 2.03M Dec/2024
Nektar Therapeutics USD 40.9M 44.19M Dec/2025
Option Care Health USD 1.28B 95.84M Mar/2026
Stryker USD 4.92B 284M Mar/2026
Surmodics USD 29.51M 274.86M Jun/2025
Trinity Biotech USD 14.82M 7.81M Sep/2025